Validations: Chain-of-Identity/Chain-of-Custody
COI/COC in Clinical vs Commercial Settings Understanding Chain-of-Identity and Chain-of-Custody in Clinical vs Commercial Settings The concepts of Chain of Identity (COI) and Chain of Custody (COC) serve as the foundation for ensuring the integrity of biologics, particularly in the context of Advanced Therapy Medicinal Products (ATMP) and viral safety validation. This article provides a comprehensive guide for pharma professionals…
Bridging COI/COC Across Countries/Regulators In the evolving landscape of biotechnology and pharmaceuticals, ensuring the integrity and safety of biologics through rigorous validation processes is paramount. This guide focuses on bridging the gaps in Chain of Identity (COI) and Chain of Custody (COC) across different regulatory environments, specifically guided by frameworks and expectations from authorities such as the US FDA, EMA,…
COI/COC KPIs: Completeness, On-Time, Error Rate COI/COC KPIs: Completeness, On-Time, Error Rate The pharmaceutical industry, especially in the realms of biologics and advanced therapy medicinal products (ATMP), demands stringent validation processes to ensure quality and compliance. Understanding key performance indicators (KPIs) for chain-of-identity (COI) and chain-of-custody (COC) is critical for achieving regulatory adherence as per guidelines set forth by agencies…
Cybersecurity in COI/COC Systems Introduction to Cybersecurity in Pharmaceutical Validation In the rapidly evolving landscape of pharmaceutical development, particularly within the domains of biologics and Advanced Therapy Medicinal Products (ATMP), the implementation of robust cybersecurity frameworks is paramount. The complexities surrounding data integrity, especially pertaining to Chain-of-Identity (COI) and Chain-of-Custody (COC) systems, necessitate stringent cybersecurity measures. This article explores the…
Interfaces Across Sites: Hospital ↔ Manufacturer Interfaces Across Sites: Hospital ↔ Manufacturer In the evolving landscape of pharmaceutical development, particularly for biologics, advanced therapy medicinal products (ATMPs), and viral safety validation, effective interfaces between hospitals and manufacturers play a pivotal role. This article serves as a comprehensive step-by-step tutorial guide, designed for professionals in the pharmaceutical industry focused on ensuring…
Data Integrity in Chain-of-Identity and Chain-of-Custody Records The management of Chain-of-Identity (COI) and Chain-of-Custody (COC) records plays a crucial role in the pharmaceutical industry, particularly in the domains of biologics, advanced therapy medicinal products (ATMP), and viral safety validation. This comprehensive guide will explore the essential principles, methods, and regulatory requirements associated with ensuring data integrity in COI/COC records, focusing…
Templates for COI/COC Logs and Chain Forms Introduction to Chain-of-Identity and Chain-of-Custody The biopharmaceutical industry demands immaculate compliance with Good Manufacturing Practices (cGMP) standards, particularly when it involves complex products such as Advanced Therapy Medicinal Products (ATMPs) and biologics. An essential component of this compliance is the assurance of Chain-of-Identity (COI) and Chain-of-Custody (COC) for materials throughout the manufacturing process….
Audit-Ready COI/COC Storyboards: A Step-by-Step Guide In the pharmaceutical industry, particularly in the development of biologics and advanced therapy medicinal products (ATMP), ensuring rigorous validation processes is essential. An integral part of this process is maintaining a comprehensive chain-of-identity (COI) and chain-of-custody (COC) system. This guide will provide you with a detailed, step-by-step approach to developing effective COI/COC storyboards that…
Supplier/Partner Roles in COI/COC Understanding Supplier and Partner Roles in Chain of Identity and Chain of Custody Introduction to Chain of Identity (COI) and Chain of Custody (COC) Chain of Identity (COI) and Chain of Custody (COC) are critical components in ensuring the integrity, quality, and safety of biological products. For products classified as Advanced Therapy Medicinal Products (ATMPs), the…
COI/COC in Decentralized Manufacturing Models Understanding COI/COC in Decentralized Manufacturing Models 1. Introduction to Chain-of-Identity and Chain-of-Custody In the realm of biologics and advanced therapy medicinal products (ATMPs), successful validation practices ensure that product integrity is maintained throughout the manufacturing process. The concepts of Chain-of-Identity (COI) and Chain-of-Custody (COC) are integral to validating decentralized manufacturing models effectively. These concepts not…